08 March 2022: Original Paper
The Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation
Betty Maillot 1ABCDEF , Guillaume Bouzille 2C , Jean-Yves Mabrut 3B , Edouard Girard 4B , Alexis Laurent 5B , Francis Navarro 6B , Alexandre Chebaro 7B , Laurence Chiche 8B , François Faitot 9B , Laurent Sulpice 1AB , Eric Vibert 10B , Karim Boudjema 1ACDEF*DOI: 10.12659/AOT.935892
Ann Transplant 2022; 27:e935892
Table 5 Patient, graft and preoperative characteristics after HT or OLT.
| HTn=59n (%) or median [IQR] | OLT*n=59n (%) or median [IQR] | P-value | |
|---|---|---|---|
| Male gender | 44 (74.6) | 44 (74.6) | 1.000 |
| Age (years) | 53 [42–59] | 55 [44–60] | 0.561 |
| Previous LT | 7 (11.9) | 0 (0) | 1.000 |
| BMI (kg/m) | 25.4 [23.4–27.1] | 24.2 [22.1–26.5] | 0.235 |
| Performance status | 0.002 | ||
| 0 | 1 (2.2) | 0 (0.0) | |
| 1 | 9 (19.6) | 0 (0.0) | |
| 2 | 9 (19.6) | 18 (31.0) | |
| 3 | 22 (47.8) | 31 (53.4) | |
| 4 | 5 (10.9) | 9 (15.5) | |
| Previous abdominal surgery | 33 (58.9) | 30 (50.8) | 0.495 |
| Previous permeable surgical shunts | 6 (10.2) | 0 (0.0) | 0.027 |
| LT indication | |||
| Cirrhosis | 19 (32.2) | 25 (42.4) | 0.341 |
| HCC | 18 (30.5) | 19 (32.2) | 1.000 |
| FH | 2 (3.4) | 3 (5.1) | 1.000 |
| PBC | 0 (0.0) | 2 (3.4) | 0.496 |
| PSC | 1 (1.7) | 2 (3.4) | 1.000 |
| Budd Chiari syndrome | 4 (6.8) | 4 (6.8) | 1.000 |
| Emergency retransplantation | 4 (6.8) | 0 (0.0) | 0.119 |
| Other | 12 (20.3) | 4 (6.8) | 0.06 |
| MELD score at LT | 16 [14–22] | 17 [13–23] | 0.992 |
| Waiting time (months) | 4 [1–9] | 5 [1–9] | 0.887 |
| Male gender | 36 (65.5) | 38 (60.3) | 0.700 |
| Age of graft (year) | 49.2 (19.6) | 54.5 (17.0) | 0.103 |
| ECD grafts | 25 (40.3) | 44 (68.8) | 0.002 |
| Duration of cold ischemia (min) | 450 [396–545] | 493 [402–600] | 0.099 |
| Intraoperative transfusion | 57 (91.9) | 55 (85.9) | 0.431 |
| Duration of surgery (min) | 455 [408–594] | 369 [303–450] | |
| * Patients were paired to HT group on sex, age, recipient BMI, indication of transplantation, MELD score and cold ischemia time. HT – hemitransposition; OLT – orthotopic liver transplantation; IQR – interquartile range; LT – liver transplantation; BMI – body mass index; HCC – hepatocellular carcinoma; FH – fulminant hepatitis; PBC – primary biliary cirrhosis; PSC – primary sclerosing cholangitis; MELD – model for end stage liver disease; ECD – extended criteria donor. | |||